{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T14:43:11Z","timestamp":1774708991828,"version":"3.50.1"},"reference-count":19,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2012,12,28]],"date-time":"2012-12-28T00:00:00Z","timestamp":1356652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Paediatrics Child Health"],"published-print":{"date-parts":[[2013,1]]},"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>To evaluate the role of atrial natriuretic peptide (<jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content>) in differentiating the aetiology of heart failure in children with left ventricular (<jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content>) volume overload.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study was conducted on 48 patients with <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content> volume overload (<jats:styled-content style=\"fixed-case\">G<\/jats:styled-content> one: rheumatic heart disease in failure; <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>2: compensated rheumatic heart disease; G3: congenital left to right shunt; and G4: dilated cardiomyopathy). Twelve healthy children served as a control group. New York Heart Association (<jats:styled-content style=\"fixed-case\">NYHA<\/jats:styled-content>) class, <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content> dimensions and functions using Vivid 7 dimensions were evaluated. Serum <jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content> was measured using the <jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content> technique, before and 3\u2009months after treatment with angiotensin converting enzyme inhibitor.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content> was raised in all patients as compared to controls (<jats:styled-content style=\"fixed-case\">G<\/jats:styled-content> one: 28.33 \u00b1 5.78, <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>2: 26.5 \u00b1 4.11, <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>3: 28.5 \u00b1 6.6, <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>4: 29.25 \u00b1 4.5\u2009pg\/mL, control group: 5.54 \u00b1 1.4\u2009pg\/mL, <jats:italic>P<\/jats:italic> &lt; 0.001 for all) and varied significantly between different <jats:styled-content style=\"fixed-case\">NYHA<\/jats:styled-content> classes regardless of the underlying cardiac lesion. It was significantly higher in group 1 than 2 (<jats:italic>P<\/jats:italic> &lt; 0.05). It decreased significantly after treatment (<jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>1: 15.3 \u00b1 5.3, <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>2: 10.7 \u00b1 2.5, <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>3: 11.5 \u00b1 3.8, <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>4: 15.7 \u00b1 10.7\u2009pg\/mL, <jats:italic>P<\/jats:italic> &lt; 0.001). The rate of change of <jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content> correlated with that of <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content> end diastolic diameter (r = 0.3, <jats:italic>P<\/jats:italic> &lt; 0.05) irrespective of the underlying cause.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">ANP<\/jats:styled-content> increases in cases of <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content> volume overload irrespective of the aetiology of heart failure. It can differentiate between children in quiescent state from those in clinical failure even in the absence of echocardiographically detectable systolic dysfunction. Furthermore, it can monitor <jats:styled-content style=\"fixed-case\">LV<\/jats:styled-content> remodelling with treatment.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jpc.12012","type":"journal-article","created":{"date-parts":[[2012,12,28]],"date-time":"2012-12-28T09:44:08Z","timestamp":1356687848000},"page":"43-47","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Atrial natriuretic peptide as a marker of heart failure in children with left ventricular volume overload"],"prefix":"10.1111","volume":"49","author":[{"given":"Alyaa A","family":"Kotby","sequence":"first","affiliation":[{"name":"Faculty of Medicine Department of Pediatric Ain Shams University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled H","family":"Taman","sequence":"additional","affiliation":[{"name":"Institute of Post Graduate Childhood Studies"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba Tallah A","family":"Sedky","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Department of Clinical Pathology Ain Shams University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevin MM","family":"Habeeb","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Department of Pediatric Ain Shams University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman S","family":"El\u2010Hadidi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine Department of Pediatric Ain Shams University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan S","family":"Yosseif","sequence":"additional","affiliation":[{"name":"Mubarak Police Hospital  Cairo Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,12,28]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"10","article-title":"Natriuretic peptide system and cardiovascular disease","volume":"11","author":"Federico C","year":"2010","journal-title":"Hear Views"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.063784"},{"key":"e_1_2_8_4_1","first-page":"405","article-title":"Atrial natriuretic peptide levels in rheumatic mitral regurgitation and response to angiotensin converting enzyme inhibitors","volume":"19","author":"Kula S","year":"2003","journal-title":"Can. J. Cardiol."},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2935937"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59259-977-6_14"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(88)90416-0"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2008.02.006"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(78)80601-5"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.02.016"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-0803.2010.00407.x"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01926-5"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2008.11.146"},{"key":"e_1_2_8_14_1","first-page":"II\u2010782","article-title":"Natriuretic peptides are potent markers for left ventricular dimensions and mass in chronic heart failure (Abstract)","volume":"102","author":"Groenning BA","year":"2000","journal-title":"Circulation"},{"key":"e_1_2_8_15_1","first-page":"165","article-title":"Influence of cardiac structure, blood flow velocity and heart function on circulating atrial natriuretic peptide and renin\u2010angiotensin system","volume":"33","author":"Hua Q","year":"1994","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00486-8"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.2004.tb02958.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/1071-9164(95)90007-1"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.2478\/s11658-007-0046-6"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)89176-X"}],"container-title":["Journal of Paediatrics and Child Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjpc.12012","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjpc.12012","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jpc.12012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T22:56:51Z","timestamp":1697324211000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jpc.12012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,28]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1111\/jpc.12012"],"URL":"https:\/\/doi.org\/10.1111\/jpc.12012","archive":["Portico"],"relation":{},"ISSN":["1034-4810","1440-1754"],"issn-type":[{"value":"1034-4810","type":"print"},{"value":"1440-1754","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,28]]},"assertion":[{"value":"2012-02-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-12-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}